IRIS

Correale, P., Botta, C., Martino, E.C., Nardone, V., Ulivieri, C., Gandolfo, C., et al. (2016). Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program. CANCER RESEARCH, 76(Suppl. 14) [10.1158/1538-7445.AM2016-2232].

Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program

Botta, C.;Nardone, V.;Ulivieri, C.;Gandolfo, C.;Baldari, C. T.;Lazzi, S.;Ginori, A.;Guidelli, G. M.;Pirtoli, L.;Giordano, A.;Cusi, M. G.
2016-01-01
2016
Correale, P., Botta, C., Martino, E.C., Nardone, V., Ulivieri, C., Gandolfo, C., et al. (2016). Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program. CANCER RESEARCH, 76(Suppl. 14) [10.1158/1538-7445.AM2016-2232].
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1063149